AstraZeneca hit by investor backlash over chief Pascal Soriot’s £19m pay deal

Vote to reject remuneration deepens concerns over London stock market exodus

The Telegraph | Finanzas | Farmacia |

Leer noticia completa en el medio original
Spanish